4.5 Review

Microbial drug discovery: 80 years of progress

Related references

Note: Only part of the references are listed.
Review Medicine, General & Internal

Medical treatment of advanced testicular cancer

Darren R. Feldman et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)

Article Biochemistry & Molecular Biology

Reversal of learning deficits in a Tsc2+/- mouse model of tuberous sclerosis

Dan Ehninger et al.

NATURE MEDICINE (2008)

Review Pharmacology & Pharmacy

Posaconazole: a new broad-spectrum antifungal agent

Douglas S. Kwon et al.

EXPERT OPINION ON PHARMACOTHERAPY (2007)

Article Medicine, General & Internal

Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis

Stephen J. Nicholls et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)

Review Plant Sciences

Natural products as sources of new drugs over the last 25 years

David J. Newman et al.

JOURNAL OF NATURAL PRODUCTS (2007)

Review Biochemistry & Molecular Biology

Role of micafungin in the antifungal armamentarium

Fumiaki Ikeda et al.

CURRENT MEDICINAL CHEMISTRY (2007)

Review Biotechnology & Applied Microbiology

New antibiotics from bacterial natural products

Jon Clardy et al.

NATURE BIOTECHNOLOGY (2006)

Review Biochemistry & Molecular Biology

Case studies in current drug development: 'glycylcyclines'

Phaik-Eng Sum

CURRENT OPINION IN CHEMICAL BIOLOGY (2006)

Review Microbiology

Invasive fungal infections: a review of epidemiology and management options

D. A. Enoch et al.

JOURNAL OF MEDICAL MICROBIOLOGY (2006)

Article Endocrinology & Metabolism

Rapamycin, an mTOR inhibitor, disrupts triglyceride metabolism in guinea pigs

Dimple Aggarwal et al.

METABOLISM-CLINICAL AND EXPERIMENTAL (2006)

Article Respiratory System

Use of tacrolimus, a potent antifibrotic agent, in bleomycin-induced lung fibrosis

J Nagano et al.

EUROPEAN RESPIRATORY JOURNAL (2006)

Article Biotechnology & Applied Microbiology

Butenyl-spinosyns, a natural example of genetic engineering of antibiotic biosynthetic genes

DR Hahn et al.

JOURNAL OF INDUSTRIAL MICROBIOLOGY & BIOTECHNOLOGY (2006)

Review Oncology

Therapeutic targets - MTOR and related pathways

Janet E. Dancey

CANCER BIOLOGY & THERAPY (2006)

Review Biotechnology & Applied Microbiology

Bioactive microbial metabolites - A personal view

J Berdy

JOURNAL OF ANTIBIOTICS (2005)

Review Pharmacology & Pharmacy

Antibiotics: where did we go wrong

KM Overbye et al.

DRUG DISCOVERY TODAY (2005)

Review Biotechnology & Applied Microbiology

Enzyme inhibitors of marine microbial origin with pharmaceutical importance

C Imada

MARINE BIOTECHNOLOGY (2004)

Review Biotechnology & Applied Microbiology

Biotechnological advantages of laboratory-scale solid-state fermentation with fungi

U Hölker et al.

APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2004)

Article Infectious Diseases

History of the development of azole derivatives

JA Maertens

CLINICAL MICROBIOLOGY AND INFECTION (2004)

Review Pharmacology & Pharmacy

Lipopeptides, focusing on daptomycin, for the treatment of Gram-positive infections

BI Eisenstein

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2004)

Article Biotechnology & Applied Microbiology

Biosynthetic gene cluster of the herbicide phosphinothricin tripeptide from Streptomyces viridochromogenes Tu494

D Schwartz et al.

APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2004)

Article Chemistry, Medicinal

Mitomycin dimers: Polyfunctional cross-linkers of DNA

MM Paz et al.

JOURNAL OF MEDICINAL CHEMISTRY (2004)

Review Pharmacology & Pharmacy

Daptomycin - a novel antibiotic against Gram-positive pathogens

KL LaPlante et al.

EXPERT OPINION ON PHARMACOTHERAPY (2004)

Article Oncology

Epothilones: Mechanism of action and biologic activity

S Goodin et al.

JOURNAL OF CLINICAL ONCOLOGY (2004)

Article Medicine, General & Internal

Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients

HJ Eisen et al.

NEW ENGLAND JOURNAL OF MEDICINE (2003)

Review Infectious Diseases

The European ban on growth-promoting antibiotics and emerging consequences for human and animal health

M Casewell et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)

Article Pharmacology & Pharmacy

Targeting mTOR signaling for cancer therapy

S Huang et al.

CURRENT OPINION IN PHARMACOLOGY (2003)

Review Agronomy

Research progress on microbial herbicides

YQ Li et al.

CROP PROTECTION (2003)

Review Biotechnology & Applied Microbiology

The future challenges facing the development of new antimicrobial drugs

A Coates et al.

NATURE REVIEWS DRUG DISCOVERY (2002)

Review Biotechnology & Applied Microbiology

Fulfilling the promise of biotechnology

RR Colwell

BIOTECHNOLOGY ADVANCES (2002)

Review Chemistry, Multidisciplinary

Natural and synthetic substances related to human health - (IUPAC Technical Report)

JG Topliss et al.

PURE AND APPLIED CHEMISTRY (2002)

Article Multidisciplinary Sciences

Curing metastatic testicular cancer

LH Einhorn

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)

Review Biochemistry & Molecular Biology

Progress towards the discovery of xanthine oxidase inhibitors

F Borges et al.

CURRENT MEDICINAL CHEMISTRY (2002)

Article Chemistry, Multidisciplinary

Engineered biosynthesis of novel spinosyns bearing altered deoxyhexose substituents

S Gaisser et al.

CHEMICAL COMMUNICATIONS (2002)

Article Infectious Diseases

Overcoming antimicrobial resistance: profile of a new ketolide antibacterial, telithromycin

R Leclercq

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2001)

Review Pharmacology & Pharmacy

Update on antifungals targeted to the cell wall:: focus on β-1,3-glucan synthase inhibitors

NH Georgopapadakou

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2001)

Article Infectious Diseases

Development of daptomycin for Gram-positive infections

FP Tally et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2000)

Article Multidisciplinary Sciences

Infectious history

J Lederberg

SCIENCE (2000)